Literature DB >> 21725840

EnRAGEd about death in type 1 diabetes.

T J Orchard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21725840     DOI： 10.1007/s00125-011-2229-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  29 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 2.  Advanced glycation end products: sparking the development of diabetic vascular injury.

Authors:  Alison Goldin; Joshua A Beckman; Ann Marie Schmidt; Mark A Creager
Journal:  Circulation       Date:  2006-08-08       Impact factor: 29.690

3.  Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE.

Authors:  Sergio Raposeiras-Roubín; Bruno K Rodiño-Janeiro; Lilian Grigorian-Shamagian; María Moure-González; Ana Seoane-Blanco; Alfonso Varela-Román; Ezequiel Alvarez; José R González-Juanatey
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

4.  Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.

Authors:  M C Thomas; J Söderlund; M Lehto; V-P Mäkinen; J L Moran; M E Cooper; C Forsblom; P-H Groop
Journal:  Diabetologia       Date:  2011-05-24       Impact factor: 10.122

5.  Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

Authors:  Colomba Falcone; Enzo Emanuele; Angela D'Angelo; Maria P Buzzi; Chiara Belvito; Mariaclara Cuccia; Diego Geroldi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

6.  The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.

Authors:  Georgia Pambianco; Tina Costacou; Trevor J Orchard
Journal:  Diabetes Care       Date:  2007-02-15       Impact factor: 19.112

7.  Awareness and treatment of dyslipidemia in young adults with type 1 diabetes.

Authors:  R Paul Wadwa; Gregory L Kinney; David M Maahs; Janet Snell-Bergeon; John E Hokanson; Satish K Garg; Robert H Eckel; Marian Rewers
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

8.  In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  T J Orchard; A M Secrest; R G Miller; T Costacou
Journal:  Diabetologia       Date:  2010-07-28       Impact factor: 10.122

9.  Trends in mortality of childhood-onset insulin-dependent diabetes mellitus in Leicestershire: 1940-1991.

Authors:  P G McNally; N T Raymond; M L Burden; P R Burton; J L Botha; P G Swift; A C Burden; J R Hearnshaw
Journal:  Diabet Med       Date:  1995-11       Impact factor: 4.359

10.  Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

Authors:  Jason B Lindsey; James A de Lemos; Francesco Cipollone; Colby R Ayers; Anand Rohatgi; David A Morrow; Amit Khera; Darren K McGuire
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.